search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
FEATURE


one was urology—cystoscopy—which placed 17th


.


The 2017 VMG Health MultiSpe- cialty ASC Intellimarker report stated that urology cases represented only 6 percent of the total case mix for ASCs in the US. It also found that urology cases generated the fourth highest median net revenue per case for ASC specialties at about $2,400 per case, behind orthopedics, otolaryngology and podiatry. For-profit ASCs want lines of services that have high net rev- enue per case and growth potential. That is urology in a nutshell. There is an incredible opportunity


for ASCs to be the site that provides the highest level of safe, compassionate, cost-effective outpatient urologic care. From a timing standpoint, the stars are aligned for urology ASC services.


Untapped Potential: Urology in the Surgery Center Setting


One-on-one with an ASC urologist INTERVIEWED BY ROBERT KURTZ


the surgery center division of Chesa- peake Urology Associates in Baltimore, Maryland. Summit ASC comprises 16 single-specialty urology ASCs located throughout Maryland.


B


Q: How is urology doing in the ASC setting? Brad Lerner: Very well, and I believe urology is uniquely positioned to be successful in the ASC arena. There is an increasing national emphasis on changing the site of ser- vice for surgical cases from inpatient to outpatient settings. Most urological services are already outpatient. Many are high-volume, short-duration and low-cost procedures. In the Medicare Payment Advi- sory Commission’s (MedPAC) March 2019 report to Congress concerning


rad Lerner, MD, CASC, is the medical director of Summit ASC,


Q: What are the most significant recent developments impacting urology in the ASC setting? BL: From a clinical standpoint, there have been many significant advance- ments. We are using new technology, doing surgeries with smaller inci- sions and using minimally invasive and other techniques that lower the risk of bleeding. For example, consider monopo- lar transurethral resection of prostate (TURP), which was historically the surgical treatment for benign pros- tatic


enlargement and obstruction. Brad Lerner, MD, CASC


Medicare payment policy, the fed- eral body included some noteworthy points concerning urology. Urology comprised only 3 percent of single- specialty ASCs. While MedPAC did not provide a number, it intimated that urology comprised a very low percentage of involvement in multi- specialty ASCs.


On the list of the 20 most frequently provided ASC services in 2017, only


12 ASC FOCUS NOVEMBER/DECEMBER 2019| ascfocus.org


This was an inpatient procedure with an increased risk of bleeding. Our treatment options now include


using different types of energy, such as laser and plasma vaporization, as well as the prostatic urethral lift and hot water vaporization procedure to treat the obstruction. These procedures can be performed on an outpatient basis with intravenous sedation or general anesthe- sia and with very low bleeding risk. Another significant clinical devel- opment concerns treatment of urinary tract stones. Much of the traditional treatment that has occurred in the hos-


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34